BioSpace News Archive

ProQR Announces Proposed Public Offering of Ordinary Shares

ProQR expects to grant the underwriters a 30-day option to purchase additional ordinary shares, on the same terms and conditions.

November 14, 2017
·
3 min read
Drug Development

Amarin: Vascepa (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients With Persistent High Triglycerides and Chronic Kidney Disease

This oral presentation was held at the American Heart Association (AHA) 2017 Scientific Sessions in Anaheim, California.

November 14, 2017
·
8 min read
Specialty Diagnostic Company IQuity Introduces First RNA-Based Blood Test to Identify IBS and IBD

IsolateIBS-IBD uses a simple blood draw to identify, with greater than 90 percent accuracy, if a patient’s RNA profile indicates the presence of IBS or IBD.

November 14, 2017
·
2 min read
Drug Development

BeiGene Expands Global Pivotal Program for BTK Inhibitor BGB-3111

Initiates global Phase 3 trial of BGB-3111 compared to bendamustine and rituximab (BR) in treatment-naïve chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) patients.

November 14, 2017
·
6 min read
Drug Development

TRACON Pharmaceuticals Announces Positive Results From Phase I Trial of TRC102 and Fludara® in Patients with Advanced Hematologic Malignancy Published in Oncotarget

Overall response rate of 24% seen with no dose limiting toxicity observed.

November 14, 2017
·
4 min read
Business

Acer Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Cash and cash equivalents were $8.4 million as of September 30, 2017, compared to $1.8 million as of December 31, 2016.

November 14, 2017
·
7 min read
Business

UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments

As of September 30, 2017, cash and cash equivalents totaled $79.2 million.

November 14, 2017
·
8 min read
BioCapital

Lonza Announces New Offering of Silensomes HLM for Drug Metabolism Studies

Today Lonza Walkersville announced its new offering of Silensomes Human Liver Microsomes products - pooled human liver microsomes for in vitro cytochrome P450 phenotyping.

November 14, 2017
·
3 min read
Business

Bionovelus Agrees to Co-Directorship and Advisory With Meroe Capital Group Ltd.

In the structure of the deal, BioNovelus will become a client of Meroe Capital’s prestigious “H2O Program II.”

November 14, 2017
·
4 min read
Business

Imprimis Pharma Announces Third Quarter 2017 Results

Gross ophthalmology-related revenue of $4.9M, up over 60% year-over-year.

November 14, 2017
·
15 min read